Monoclonal antibodies targeting novel sites of vulnerability in marburg virus glycoprotein

Information

• Research Project
• 9845669

• ApplicationId

  9845669

• Core Project Number

  R41AI147929

• Full Project Number

  1R41AI147929-01

• Serial Number

  147929

• FOA Number

  PA-18-575

• Sub Project Id

• Project Start Date

  7/12/2019 - 5 years ago

• Project End Date

  6/30/2021 - 3 years ago

• Program Officer Name

  REPIK, PATRICIA M

• Budget Start Date

  7/12/2019 - 5 years ago

• Budget End Date

  6/30/2020 - 4 years ago

• Fiscal Year

  2019

• Support Year

  01

• Suffix

• Award Notice Date

  7/12/2019 - 5 years ago

Organizations

• INTEGRATED BIOTHERAPEUTICS, INC.

IC Name

• Activity

  R41

• Administering IC

  AI

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  300000

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:300000\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  INTEGRATED BIOTHERAPEUTICS, INC.

• Organization Department

• Organization DUNS

  601000750

• Organization City

  ROCKVILLE

• Organization State

  MD

• Organization Country

  UNITED STATES

• Organization Zip Code

  208503855

• Organization District

  UNITED STATES